Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G protein-coupled receptor 132 (GPR132 or G2A) is a member of the proton-sensing G protein-coupled receptor subfamily, characterized by seven transmembrane domains. It functions predominantly as a sensor of extracellular pH and may serve as a receptor for oxidized polyunsaturated fatty acid metabolites, especially oxidized linoleic and arachidonic acid derivatives like 9-HODE, as well as N-palmitoylglycine. GPR132 is highly expressed in immune cells, including macrophages, lymphocytes, and natural killer cells, where it regulates functions such as cell migration, proliferation, differentiation, and responses to metabolic and inflammatory stimuli. It acts through G protein signaling (notably Gα_s and Gα_13) and is implicated in the regulation of cell cycle, apoptosis, immune responses, and maintenance of cellular homeostasis during oxidative stress. GPR132 has demonstrated roles in tumor suppression, modulation of NK cell cytotoxicity, and is involved in the pathogenesis of cholesterol gallstone disease. Its precise ligand profile and mechanisms continue to be actively studied[1][3][5][7][9].
Activation via proton-sensing at acidic extracellular pH which leads to cellular signal transduction; Ligand binding (e.g., oxidized fatty acids, N-palmitoylglycine) triggers downstream G protein (mainly Gα_s and Gα_13) signaling and phospholipase C activation; Inhibition of immune cell cytotoxicity via Gα_s/CSK/ZAP70/NF-κB pathway in natural killer (NK) cells
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G protein-coupled receptor 132 (GPR132).